Restart Life Sciences Corp. NMLSF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -734.50K | -237.70K | -112.80K | -153.20K | -147.10K |
| Total Depreciation and Amortization | 6.70K | 2.90K | 300.00 | 300.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 506.80K | 89.80K | 174.50K | 32.50K | 34.90K |
| Change in Net Operating Assets | -141.90K | 91.00K | -295.50K | 63.10K | 55.70K |
| Cash from Operations | -363.00K | -54.00K | -233.50K | -57.30K | -56.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -615.70K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.90K | -- | -- | -- | -- |
| Cash from Investing | -71.90K | -615.70K | -- | -- | -- |
| Total Debt Issued | -- | -- | 250.00K | -- | -- |
| Total Debt Repaid | -8.90K | -5.00K | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 110.00K | 474.70K | 1.59M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.70K | -7.80K | -- | -- | -- |
| Cash from Financing | 69.60K | 336.70K | 1.32M | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -365.20K | -333.00K | 1.08M | -57.30K | -56.10K |